e.l.f. Beauty, Inc. (ELF) stock
ELFNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3027% above fair value
$113.53−4.93 (-4.16%)
Close on Nov 12, 2026Market cap $6.70BP/E 78.3Yield –
Earnings
e.l.f. Beauty's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 3, 2027
Q3 FY2027 · estimated, after the close
Revenue, Q2 FY2027
$520.80M
+51.4% on a year earlier
Adjusted diluted earnings per share, Q2 FY2027
$1.21
$0.68 a year earlier
Latest guidance
Issued
Nov 4, 2026 · 6 items
Quarterly results
Revenue and earnings per share from each of e.l.f. Beauty's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Dec 31, 2026 | Feb 3, 2027Expected | – | – | – | – | – |
| Q2 FY2027ended Sep 30, 2026 | Nov 4, 2026after the close | $520.80M | +51.4% | $0.50 | $1.21 | Release |
| Q1 FY2027ended Jun 30, 2026 | Aug 5, 2026after the close | $479.40M | +35.5% | $1.12 | $1.75 | Release |
| Q4 FY2026ended Mar 31, 2026 | May 20, 2026after the close | $449.30M | – | -$0.82 | $0.32 | Release |
| Q3 FY2026ended Dec 31, 2025 | Feb 4, 2026after the close | $489.50M | +37.8% | $0.65 | $1.24 | Release |
| Q2 FY2026ended Sep 30, 2025 | Nov 5, 2025after the close | $343.90M | +14.2% | $0.05 | $0.68 | Release |
| Q1 FY2026ended Jun 30, 2025 | Aug 6, 2025after the close | $353.70M | +9.0% | $0.58 | $0.89 | Release |
| Q3 FY2025ended Dec 31, 2024 | Feb 6, 2025after the close | $355.30M | +31.2% | $0.30 | $0.74 | Release |
| Q2 FY2025ended Sep 30, 2024 | Nov 6, 2024after the close | $301.10M | +39.7% | $0.33 | $0.77 | Release |
| Q1 FY2025ended Jun 30, 2024 | Aug 8, 2024after the close | $324.50M | +50.0% | $0.81 | $1.10 | Release |
| Q4 FY2024ended Mar 31, 2024 | May 22, 2024after the close | $321.10M | +71.3% | $0.25 | $0.53 | Release |
| Q3 FY2024ended Dec 31, 2023 | Feb 6, 2024after the close | $270.90M | +84.9% | $0.46 | $0.74 | Release |
| Q2 FY2024ended Sep 30, 2023 | Nov 1, 2023after the close | $215.50M | +76.2% | $0.58 | $0.82 | Release |
| Q1 FY2024ended Jun 30, 2023 | Aug 1, 2023after the close | $216.30M | +76.4% | $0.93 | $1.10 | Release |
| Q4 FY2023ended Mar 31, 2023 | May 24, 2023after the close | $187.40M | +78.3% | $0.29 | $0.42 | Release |
| Q3 FY2023ended Dec 31, 2022 | Feb 1, 2023after the close | $146.50M | +49.3% | $0.34 | $0.48 | Release |
| Q2 FY2023ended Sep 30, 2022 | Nov 2, 2022after the close | $122.30M | +33.1% | $0.21 | $0.36 | Release |
| Q1 FY2023ended Jun 30, 2022 | Aug 3, 2022after the close | $122.60M | – | $0.27 | $0.39 | Release |
| Q4 FY2022ended Mar 31, 2022 | May 25, 2022after the close | $105.10M | – | $0.03 | $0.13 | Release |
| Q3 FY2022ended Dec 31, 2021 | Feb 2, 2022after the close | $98.10M | – | $0.12 | $0.24 | Release |
| Q2 FY2022ended Sep 30, 2021 | Nov 3, 2021after the close | $91.90M | – | $0.11 | $0.21 | Release |
| Q1 FY2022ended Jun 30, 2021 | Aug 4, 2021after the close | – | – | – | – | Filing |
| Q4 FY2021ended Mar 31, 2021 | May 26, 2021after the close | – | – | – | – | Filing |
| Q3 FY2021ended Dec 31, 2020 | Feb 3, 2021after the close | – | – | – | – | Filing |
| Q2 FY2021ended Sep 30, 2020 | Nov 4, 2020after the close | – | – | – | – | Filing |
| Q1 FY2021ended Jun 30, 2020 | Aug 5, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
e.l.f. Beauty's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | FY2027 | $2.00B – $2.03B | – | New | Nov 4, 2026 |
| Net sales | FY2027 | $1.94B – $1.97B | – | New | Aug 5, 2026 |
| net sales growth | FY2027 | +18% – +20% | +12% – +14% | Raised | Aug 5, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $421.00M – $427.00M | – | New | Nov 4, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $401.00M – $407.00M | – | New | Aug 5, 2026 |
| Adjusted diluted earnings per sharenon-GAAP | FY2027 | $3.82 – $3.86 | – | New | Nov 4, 2026 |
| Adjusted diluted earnings per sharenon-GAAP | FY2027 | $3.50 – $3.55 | – | New | Aug 5, 2026 |
| Adjusted effective tax ratenon-GAAP | FY2027 | 25% – 26% | – | New | Nov 4, 2026 |
| Adjusted net incomenon-GAAP | FY2027 | $231.00M – $233.00M | – | New | Nov 4, 2026 |
| Adjusted net incomenon-GAAP | FY2027 | $212.00M – $215.00M | – | New | Aug 5, 2026 |
| Weighted average diluted shares outstanding | FY2027 | 60.5 | – | New | Nov 4, 2026 |
| Weighted average diluted shares outstanding | FY2027 | 60.5 | – | New | Aug 5, 2026 |
Guidance vs results
The last range e.l.f. Beauty gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Adjusted diluted earnings per share | $3.05 – $3.10 | $3.13Σ4Q | Above range |
| FY2026 | Revenue | $1.60B – $1.61B | $1.64BΣ4Q | Above range |
Guidance history
Every forecast e.l.f. Beauty put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 4, 2026 | Adjusted EBITDA | FY2027 | $421.00M – $427.00M | New |
| Nov 4, 2026 | Adjusted diluted earnings per share | FY2027 | $3.82 – $3.86 | New |
| Nov 4, 2026 | Adjusted net income | FY2027 | $231.00M – $233.00M | New |
| Nov 4, 2026 | Adjusted effective tax rate | FY2027 | 25% – 26% | New |
| Nov 4, 2026 | Weighted average diluted shares outstanding | FY2027 | 60.5 | New |
| Nov 4, 2026 | Net sales | FY2027 | $2.00B – $2.03B | New |
| Aug 5, 2026 | Adjusted EBITDA | FY2027 | $401.00M – $407.00M | New |
| Aug 5, 2026 | Adjusted diluted earnings per share | FY2027 | $3.50 – $3.55 | New |
| Aug 5, 2026 | Weighted average diluted shares outstanding | FY2027 | 60.5 | New |
| Aug 5, 2026 | Adjusted net income | FY2027 | $212.00M – $215.00M | New |
| Aug 5, 2026 | net sales growth | FY2027 | +18% – +20% | Raised |
| Aug 5, 2026 | Net sales | FY2027 | $1.94B – $1.97B | New |
| May 20, 2026 | net sales | FY2027 | +12% – +14% | New |
| Feb 4, 2026 | Adjusted EBITDA | FY2026 | $323.00M – $326.00M | New |
| Feb 4, 2026 | Adjusted diluted earnings per share | FY2026 | $3.05 – $3.10 | New |
| Feb 4, 2026 | Adjusted net income | FY2026 | $180.00M – $183.00M | New |
| Feb 4, 2026 | Diluted shares outstanding | FY2026 | 59 | New |
| Feb 4, 2026 | Adjusted effective tax rate | FY2026 | 23% | New |
| Feb 4, 2026 | Net sales | FY2026 | $1.60B – $1.61B | New |
| Nov 5, 2025 | net sales | FY2026 | +18% – +20% | New |
| Aug 6, 2025 | Adjusted EBITDA margins | FY2026 | 20% | New |
| Aug 6, 2025 | Net sales growth | FY2026 | +9% | New |
| Nov 6, 2024 | Adjusted EBITDA | FY2025 | $304.00M – $308.00M | Raised |
| Nov 6, 2024 | Adjusted diluted earnings per share | FY2025 | $3.47 – $3.53 | Raised |
| Nov 6, 2024 | Adjusted net income | FY2025 | $205.00M – $208.00M | Raised |
| Nov 6, 2024 | Fiscal year ending diluted shares outstanding | FY2025 | 59 | Reaffirmed |
| Nov 6, 2024 | Adjusted effective tax rate | FY2025 | 19% – 20% | Lowered |
| Nov 6, 2024 | net sales | FY2025 | +28% – +30% | Raised |
| Nov 6, 2024 | Net sales | FY2025 | $1.32B – $1.34B | Raised |
| Aug 8, 2024 | Adjusted EBITDA | FY2025 | $297.00M – $301.00M | Raised |
| Aug 8, 2024 | Adjusted diluted earnings per share | FY2025 | $3.36 – $3.41 | Raised |
| Aug 8, 2024 | Adjusted net income | FY2025 | $198.00M – $201.00M | Raised |
| Aug 8, 2024 | Fiscal year ending diluted shares outstanding | FY2025 | 59 | Reaffirmed |
| Aug 8, 2024 | increase in net sales | FY2025 | +25% – +27% | New |
| Aug 8, 2024 | Net sales | FY2025 | $1.28B – $1.30B | New |
| May 22, 2024 | Adjusted EBITDA | FY2025 | $285.00M – $289.00M | New |
| May 22, 2024 | Adjusted diluted earnings per share | FY2025 | $3.20 – $3.25 | New |
| May 22, 2024 | Weighted average diluted shares outstanding | FY2025 | 59 | New |
| May 22, 2024 | Adjusted effective tax rate | FY2025 | 20% – 21% | New |
| May 22, 2024 | Adjusted net income | FY2025 | $187.00M – $191.00M | New |
| May 22, 2024 | Net sales | FY2025 | $1.23B – $1.25B | New |
| Feb 6, 2024 | Adjusted EBITDA | FY2024 | $218.00M – $220.00M | Raised |
| Feb 6, 2024 | Adjusted diluted earnings per share | FY2024 | $2.84 – $2.87 | Raised |
| Feb 6, 2024 | Fiscal year ending diluted shares outstanding | FY2024 | 58 | Reaffirmed |
| Feb 6, 2024 | Adjusted effective tax rate | FY2024 | 14% | Lowered |
| Feb 6, 2024 | Adjusted net income | FY2024 | $164.00M – $166.00M | Raised |
| Feb 6, 2024 | Net sales | FY2024 | $980.00M – $990.00M | Raised |
| Nov 1, 2023 | Adjusted EBITDA | FY2024 | $197.00M – $200.00M | Raised |
| Nov 1, 2023 | Adjusted diluted earnings per share | FY2024 | $2.47 – $2.50 | Raised |
| Nov 1, 2023 | Fiscal year ending diluted shares outstanding | FY2024 | 58 | Raised |
| Nov 1, 2023 | Adjusted effective tax rate | FY2024 | 17% – 18% | Reaffirmed |
| Nov 1, 2023 | Adjusted net income | FY2024 | $144.00M – $146.00M | Raised |
| Nov 1, 2023 | Net sales | FY2024 | $896.00M – $906.00M | New |
| Aug 1, 2023 | Adjusted EBITDA | FY2024 | $171.00M – $174.00M | Raised |
| Aug 1, 2023 | Adjusted diluted earnings per share | FY2024 | $2.19 – $2.22 | Raised |
| Aug 1, 2023 | Fiscal year ending diluted shares outstanding | FY2024 | 57 | New |
| Aug 1, 2023 | Adjusted effective tax rate | FY2024 | 17% – 18% | Lowered |
| Aug 1, 2023 | Adjusted net income | FY2024 | $125.00M – $127.00M | Raised |
| Aug 1, 2023 | Net sales | FY2024 | $792.00M – $802.00M | Raised |
| May 24, 2023 | Adjusted EBITDA | FY2024 | $144.50M – $147.50M | New |
| May 24, 2023 | Adjusted diluted earnings per share | FY2024 | $1.73 – $1.76 | New |
| May 24, 2023 | Weighted average diluted shares outstanding | FY2024 | 57 | New |
| May 24, 2023 | Adjusted effective tax rate | FY2024 | 21% – 22% | New |
| May 24, 2023 | Adjusted net income | FY2024 | $98.50M – $100.50M | New |
| May 24, 2023 | Net sales | FY2024 | $705.00M – $720.00M | New |
| Feb 1, 2023 | Adjusted EBITDA | FY2023 | $110.50M – $112.00M | Raised |
| Feb 1, 2023 | Adjusted diluted earnings per share | FY2023 | $1.37 – $1.40 | Raised |
| Feb 1, 2023 | Fiscal year ending diluted shares outstanding | FY2023 | 56 | Reaffirmed |
| Feb 1, 2023 | Adjusted effective tax rate | FY2023 | 19% | Lowered |
| Feb 1, 2023 | Adjusted net income | FY2023 | $75.50M – $77.00M | Raised |
| Feb 1, 2023 | Net sales | FY2023 | $541.00M – $545.00M | New |
| Nov 2, 2022 | Adjusted EBITDA | FY2023 | $93.50M – $95.00M | Raised |
| Nov 2, 2022 | Adjusted diluted earnings per share | FY2023 | $1.07 – $1.10 | Raised |
| Nov 2, 2022 | Adjusted net income | FY2023 | $59.00M – $60.50M | Raised |
| Nov 2, 2022 | Adjusted effective tax rate | FY2023 | 22% – 23% | Lowered |
| Nov 2, 2022 | Fiscal year ending diluted shares outstanding | FY2023 | 56 | Reaffirmed |
| Nov 2, 2022 | Net sales | FY2023 | $478.00M – $486.00M | Raised |
| Aug 3, 2022 | Adjusted EBITDA | FY2023 | $83.50M – $85.00M | Raised |
| Aug 3, 2022 | Adjusted diluted earnings per share | FY2023 | $0.84 – $0.87 | Raised |
| Aug 3, 2022 | Adjusted effective tax rate | FY2023 | 25% – 26% | Lowered |
| Aug 3, 2022 | Adjusted net income | FY2023 | $47.00M – $48.50M | Raised |
| Aug 3, 2022 | Weighted average diluted shares outstanding | FY2023 | 56 | Reaffirmed |
| Aug 3, 2022 | Net sales | FY2023 | $448.00M – $456.00M | Raised |
| May 25, 2022 | Adjusted EBITDA | FY2023 | $80.50M – $82.00M | New |
| May 25, 2022 | Adjusted diluted earnings per share | FY2023 | $0.78 – $0.81 | New |
| May 25, 2022 | Adjusted effective tax rate | FY2023 | 27% – 28% | New |
| May 25, 2022 | Weighted average diluted shares outstanding | FY2023 | 56 | New |
| May 25, 2022 | Adjusted net income | FY2023 | $43.50M – $45.50M | New |
| May 25, 2022 | Net sales | FY2023 | $432.00M – $440.00M | New |
| Feb 2, 2022 | Adjusted EBITDA | FY2022 | $70.00M – $72.00M | Raised |
| Feb 2, 2022 | Adjusted diluted earnings per share | FY2022 | $0.73 – $0.76 | Raised |
| Feb 2, 2022 | Weighted average diluted shares outstanding | FY2022 | 55 | Reaffirmed |
| Feb 2, 2022 | Adjusted effective tax rate | FY2022 | 22% – 23% | Lowered |
| Feb 2, 2022 | Adjusted net income | FY2022 | $40.00M – $42.00M | Raised |
| Feb 2, 2022 | Net sales | FY2022 | $372.00M – $379.00M | New |
| Nov 3, 2021 | Adjusted EBITDA | FY2022 | $66.50M – $68.00M | New |
| Nov 3, 2021 | Adjusted diluted earnings per share | FY2022 | $0.65 – $0.68 | New |
| Nov 3, 2021 | Weighted average diluted shares outstanding | FY2022 | 55 | New |
| Nov 3, 2021 | Adjusted effective tax rate | FY2022 | 23% – 24% | New |
| Nov 3, 2021 | Adjusted net income | FY2022 | $36.00M – $37.50M | New |
| Nov 3, 2021 | Net sales | FY2022 | $364.00M – $370.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases e.l.f. Beauty filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Update
- Results
- Results
- News
- Results
- Results
- Results
- Results
See a number that looks wrong?